Skip to content

Cencora COR Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

AbbVie logo
AbbVieABBV
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$78.4B+3.8%
Gross profit$3.6B+17.3%
Operating income$1.1B+10.3%
Net income$1.6B+129%
EPS (diluted)$8.40+128%

Balance sheet

See full
Cash & equivalents$2.2B+10.0%
Total debt$12.2B+71.9%
Total equity$3.4B+235%
Total assets$81.7B+14.7%

Cash flow

See full
Operating cash flow-$2.3B+15.2%
CapEx$165.6M+28.3%
Free cash flow-$2.4B+14.2%

Valuation

See full
Market cap$55.06B-0.1%
Enterprise value$65.06B+6.5%
P/E15.3×+3.1×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.4pp
Operating margin0.8%0.0pp
Net margin0.6%-0.1pp
FCF margin1.1%+1.0pp

Returns & leverage

See full
Return on equity130.6%-99.8pp
Debt / equity3.6×-3.4×
Current ratio0.9×+0.1×

Where this comes from

Reported directly by Cencora in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Cencora’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cencora's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cencora's interest income (expense), nonoperating?
Cencora (COR) reported interest income (expense), nonoperating of -$140.46M in Q1 2026.
How has Cencora's interest income (expense), nonoperating changed year-over-year?
Cencora's interest income (expense), nonoperating decreased by 35.1% year-over-year, from -$103.99M to -$140.46M.
What is the long-term trend for Cencora's interest income (expense), nonoperating?
Over 4 years (2021 to 2025), Cencora's interest income (expense), nonoperating has grown at a 13.8% compound annual growth rate (CAGR), from -$174.07M to -$291.55M.
What does interest income (expense), nonoperating mean?
This represents the net cost or benefit of the company's debt and cash holdings, excluding interest related to operating leases or specific financing arrangements. It reflects the interest expense incurred on outstanding debt obligations offset by interest income earned on cash and cash equivalents. It is a key indicator of the company's financial leverage and the cost of servicing its capital structure.